What is the likely cause and recommended management for bilateral breast enlargement in a 13‑day‑old male infant?

Bilateral Breast Swelling in a 13-Day-Old Male Infant

This is physiologic neonatal gynecomastia caused by transplacental maternal hormones, particularly prolactin, and requires only reassurance with no intervention. 1

Etiology and Pathophysiology

Bilateral breast enlargement in a 13-day-old male is a normal physiologic phenomenon occurring in neonates due to:

• Transplacental passage of maternal estrogens and prolactin during pregnancy
• Elevated neonatal prolactin levels that persist beyond the first week of life and correlate directly with the degree and duration of breast enlargement 2
• Hormonal stimulation of breast tissue that occurs in both male and female neonates

The ACR guidelines explicitly state that gynecomastia "occurs physiologically in neonates" as one of three normal life stages (along with adolescence and aging >65 years) 1. Recent research demonstrates that breast enlargement persisting beyond the first postnatal week shows positive correlation with serum prolactin levels, with complete regression occurring as prolactin normalizes over several weeks 2.

Clinical Characteristics to Confirm Benign Etiology

The presentation should demonstrate:

• Bilateral involvement (though can be asymmetric)
• Soft, rubbery, or firm mobile tissue directly under the nipple
• No associated skin changes (no erythema, warmth, induration, or discharge)
• No systemic symptoms (no fever, irritability, or feeding difficulties)
• Otherwise healthy full-term or near-term infant

Management Algorithm

Immediate Management (Day 13 of Life):

1. Reassure parents that this is a normal, self-limited condition
2. No imaging is indicated - neither ultrasound nor any other modality 1
3. No laboratory testing required unless clinical features are atypical
4. Avoid manipulation or compression of the breast tissue

Follow-Up Strategy:

• Expectant observation only - the condition will spontaneously resolve over weeks to months 2, 3
• No scheduled follow-up specifically for breast swelling unless parents have concerns
• Resolution typically occurs by several weeks to months as prolactin levels normalize 2

Critical Red Flags Requiring Further Evaluation

Immediate further workup is needed ONLY if:

• Unilateral involvement with hard, fixed mass (extremely rare malignancy consideration)
• Skin changes: erythema, warmth, fluctuance suggesting mastitis or abscess
• Purulent nipple discharge
• Systemic illness: fever, poor feeding, lethargy
• Rapid progressive enlargement beyond expected physiologic course

If any red flags present, then ultrasound becomes the first-line imaging modality to distinguish between abscess, mastitis, or the extraordinarily rare neonatal breast malignancy 4.

Common Pitfalls to Avoid

1. Do NOT order imaging for physiologic neonatal gynecomastia - this causes unnecessary anxiety, cost, and potential harm to developing breast tissue 4

2. Do NOT obtain hormone levels (testosterone, estradiol, LH, FSH, prolactin) in typical cases - these are only indicated if clinical features suggest endocrine pathology (ambiguous genitalia, other congenital anomalies) 3

3. Do NOT refer to pediatric endocrinology or surgery for uncomplicated bilateral breast swelling in a neonate

4. Do NOT attempt aspiration or biopsy - this risks infection, damage to breast bud, and is completely unnecessary for physiologic gynecomastia

5. Avoid confusing this with pathologic conditions that occur in older males - the differential diagnosis and management for neonatal breast enlargement is entirely different from adolescent or adult gynecomastia

Key Distinction from Pathologic Gynecomastia

While the ACR guidelines extensively discuss evaluation of symptomatic male breast conditions 1, these protocols apply to older males where cancer risk exists and hormonal/medication causes must be investigated. In contrast, neonatal physiologic gynecomastia at 13 days of life requires zero workup - it is an expected finding that resolves spontaneously as maternal hormones clear from the infant's system.

The 2024 research confirms that even pronounced breast enlargement beyond the first week correlates with prolactin levels and undergoes complete regression without intervention 2, reinforcing that observation alone is appropriate management.